Table 1.
Characteristic | Total (n = 330) | Group 1 (n = 233) | Group 2 (n = 97) | 1 vs 2 p |
---|---|---|---|---|
Age (years) | 0.312a | |||
M ± SD | 72.1 ± 7.9 | 72.0 ± 7.5 | 72.4 ± 8.9 | |
Me (Q1; Q3) | 69 (66; 77) | 69 (66; 77) | 71 (66; 77) | |
Female | 148 (44.9%) | 102 (43.8%) | 46 (47.4%) | |
Comorbidities | ||||
Diabetes mellitus | 159 (48.2%) | 117 (50.2%) | 42 (43.3%) | 0.306b |
Hypertension | 264 (80.0%) | 189 (81.1%) | 75 (77.3%) | 0.526b |
COPD | 90 (27,3%) | 61 (26.2%) | 28 (28.9%) | 0.680b |
Renal insufficiency | 53 (16.1%) | 30 (12.9%) | 20 (20.6%) | 0.255b |
NYHA class | < 0.001c | |||
I | 19 (5.8%) | 19 (8.2%) | 0 (0.0%) | |
II | 160 (48.5%) | 121 (51.9%) | 39 (40.2%) | |
III | 133 (40.3%) | 85 (36.5%) | 48 (49.5%) | |
IV | 18 (5.4%) | 8 (3.4%) | 10 (10.3) | |
Left ventricular ejection fraction (EF) (%) | 0.002a | |||
M ± SD | 39.7 ± 9.4 | 40.5 ± 8.9 | 37.7 ± 10.5 | |
Me (Q1; Q3) | 40 (35; 45) | 42 (35; 46) | 35 (30; 45) | |
Min ÷ Max | 15 ÷ 70 | 15 ÷ 65 | 18 ÷ 70 | |
Frailty syndrome (TFI) | 214 (64.8%) | 145 (62.2%) | 69 (71.1%) | 0.157b |
TFI physical domain | 0.102a | |||
M ± SD | 3.9 ± 2.0 | 3.8 ± 2.0 | 4.2 ± 2.0 | |
Me (Q1; Q3) | 4 (2; 5) | 4 (2; 5) | 4 (3; 5) | |
Min ÷ Max | 0 ÷ 8 | 0 ÷ 8 | 1 ÷ 8 | |
TFI psychological domain | 0.436a | |||
M ± SD | 1.7 ± 1.0 | 1.7 ± 1.0 | 1.8 ± 1.0 | |
Me (Q1; Q3) | 2 (1; 2) | 2 (1; 2) | 2 (1; 3) | |
Min ÷ Max | 0 ÷ 4 | 0 ÷ 4 | 0 ÷ 4 | |
TFI social domain | <0.001a | |||
M ± SD | 1.3 ± 0.9 | 1.2 ± 0.9 | 1.5 ± 0.9 | |
Me (Q1; Q3) | 1 (1; 2) | 1 (1; 2) | 1 (1; 2) | |
Min ÷ Max | 0 ÷ 5 | 0 ÷ 3 | 0 ÷ 5 |
M mean, SD standard deviation, Me median, Q1 lower quartile (25th percentile), Q3 upper quartile (75th percentile), Min lowest value, Max highest value, a Mann–Whitney U test, b Yates’ Chi-squared test, c Pearson’s Chi-squared test, TFI Tilburg Frailty Indicator, NYHA New York Heart Association Functional classification, EF ejection fraction, COPD chronic obstructive pulmonary disease